Abacus Global Management, Inc.
ABX
NYSE·Financial Services·Insurance - Life·Mkt cap $921.8M
$9.61
▼ -1.44%
P/E
32.82
Mkt Cap
$921.8M
52-Wk Range
$5.00–$12.44
52-Week Range
$5.00 - $12.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 44.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in the niche life settlements and alternative assets market with 20+ years of operating history
- Proprietary technology infrastructure for mortality verification and missing participant identification
- Integrated business model providing end-to-end solutions from origination through portfolio servicing
- Multiple revenue channels and distribution networks including financial advisors, direct-to-consumer, and traditional intermediaries
Bear Case
1 risk
- Low volatility (beta 0.1).
Growth
Moderate growth ahead
Increasing institutional and retail adoption of alternative investment assets seeking non-correlated returns
Value
Valued in line with Life Insurance peers (1.0x).
Momentum
Strong
+10.3% over 3m
Quality
Excellent
High-growth business (85% revenue growth, 69% gross margin). Profitable with strong growth momentum.
Dividend
Solid
2.08% yield
Smart-money signal
Who's buying ABX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $0.28 vs $0.24 consensus (+16.7% surprise). Revenue of $73.0M vs $66.2M expected (+10.4%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+16.7%
Revenue trend · last 8Q
—
—
+94%
+93%
+122%
+124%
+72%
+30%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$23.9M
$27.4M
$34.5M
$47.5M
$53.2M
$61.2M
$59.4M
$73.0M
Margins · last 8Q
Gross
87.6%
Operating
29.4%
Profit
9.1%
Wall Street consensus
2 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: B. Riley · Aug 7, 2026
vs Industry
How ABX stacks vs Insurance - Life
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related